The Sublimated Mare Milk Supplement in Hepatitis C

• Status: Completed
• Trial end date: 2020-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This clinical trial studies the effect of sublimated mare milk supplement on patients with hepatitis C.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asfendiyarov Kazakh National Medical University
• Collaborators: Eurasia Invest Ltd.; Ministry of Education and Science, Republic of Kazakhstan

Criteria

Inclusion Criteria:

• Patients with verified diagnosis of hepatitis C

• Aged 18 to 65 years

• Normal intestinal microbiota composition (anaerobes-95%, aerobes-5%)

• Normal level of immune system markers in blood (Immunoglobulin M and Immunoglobulin G)

• Decreased levels of phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine, sphingomyelin

• Elevated lysophosphatidylcholine

• Willingness to consent to participate in the study

• Consent to adhere to treatment

Exclusion Criteria:

• Drug and/or alcohol dependence

• Allergy to dairy products

• People with mental disabilities and/or life-threatening conditions

• Pregnancy and/or lactation

• Lactose intolerance

• Refusal to participate in the study